School of Medicine
Showing 1-100 of 145 Results
-
Alison Callahan
Research Engineer, Med/BMIR
BioAlison Callahan is a research scientist in the Center for Biomedical Informatics and a member of the Shah Lab. Her work involves research and development of informatics methods for the analysis of biomedical and clinical data, to derive insights and inform medical decision making.
Alison completed her PhD in the Department of Biology at Carleton University in Ottawa, Canada. Her doctoral research focused on developing HyQue, a framework for representing and evaluating scientific hypotheses, and applying this framework to discover genes related to aging. She was also a developer for Bio2RDF, an open-source project to build and provide the largest network of Linked Data for the life sciences. -
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsClinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
-
Chris Cartwright, MD
Professor of Medicine (Gastroenterology and Hepatology), Emerita
Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.
-
Jennifer Caswell-Jin
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
-
Arianna Celis Luna
Postdoctoral Research Fellow, Infectious Diseases
BioArianna I. Celis Luna is a postdoctoral fellow in the lab of Dr. David Relman. Her research will investigate the role of the GI microbiome on iron absorption during pregnancy. She aims is to elucidate a functional role for the microbiome during this critical time period by combining metatranscriptomic and metametabolomic data from in vivo samples with biochemical data from in vitro samples. She hopes to shed light on how iron-deficiency anemia, still affecting ~50% of pregnant women in developed countries, can be more efficiently treated or prevented.
Arianna received her Ph.D. in Biochemistry from Montana State University in 2018. She worked in the lab of Dr. Jennifer DuBois where her research focused on how, at the molecular level, bacteria build iron into the versatile molecule known as heme and break it apart again. Her work examined how these reactions are critical for both pathogenic species, such as Staphylococcus aureus, and the resident bacteria of the digestive tract.
Arianna’s work encompasses 6 published papers in journals like the Journal of the American Chemical Society, the Journal of Biological Chemistry, and ACS Biochemistry. She has presented her work in several conferences, including Gordon Research Conferences and the ASBMB Annual Meeting, and at Montana State University as part of the Kopriva Science Seminar Series after receiving the Kopriva Graduate Student Fellowship. -
Yashaar Chaichian
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsSystemic lupus erythematosus
CTD-associated interstitial lung disease -
David Chan
Assistant Professor of Medicine (PCOR)
BioDavid Chan, MD, PhD, is an Assistant Professor of Medicine at the Stanford School of Medicine, an investigator at the Department of Veterans Affairs, and a Faculty Research Fellow at the National Bureau of Economic Research. Drawing on labor and organizational economics, he is interested in studying how information is used in health care, how this affects productivity, and implications for design. He is the recipient of the 2014 NIH Director’s High-Risk, High-Reward Early Independence Award to study the optimal balance of information in health information technology for patient care.
Dr. Chan received master’s degrees in policy and economics from the London School of Economics and Oxford University, where he studied as a Marshall scholar. He holds a medical degree from UCLA and a PhD in economics from MIT. He trained in internal medicine at Brigham and Women’s Hospital and was an instructor of medicine at Harvard Medical School, prior to coming to Palo Alto, where he currently is a hospitalist at the Department of Veterans Affairs, Palo Alto. -
Stephen Chang, MD, PhD
Clinical Scholar, Medicine - Cardiovascular Medicine
Postdoctoral Research Fellow, BiochemistryBioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease. -
Tara I. Chang
Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center
Current Research and Scholarly InterestsMy research focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with chronic kidney disease, with the long-term goal of improving cardiovascular outcomes in these high-risk patients.
-
Jonathan H. Chen, MD, PhD
Assistant Professor of Medicine (Biomedical Informatics) at the Stanford University Medical Center
Current Research and Scholarly InterestsInformatics solutions ares the only credible approach to systematically address challenges of escalating complexity in healthcare. Tapping into real-world clinical data streams like electronic medical records will reveal the community's latent knowledge in a reproducible form. Delivering this back as clinical decision support will uniquely close the loop on a continuously learning health system.
-
Julie Chen
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioJulie Chen, MD, is a clinical assistant professor in endocrinology at Stanford University. Dr. Chen graduated from Albert Einstein College of Medicine. She then completed her internal medicine residency at the University of California, San Diego and endocrinology fellowship at Stanford University Medical Center. She is double board certified in internal medicine and endocrinology.
Dr. Chen practices general endocrinology but her clinical interest include thyroid disease/thyroid cancer, pituitary disease, and disorders of the bone. She also has a special interest in medical education and has developed online teaching resources for the endocrine fellowship program. -
Meng Chen, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Chen is a board-certified, fellowship-trained specialist in allergy/immunology and internal medicine. She is a clinical assistant professor in the Department of Internal Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University School of Medicine.
With training in pediatric and adult allergy/immunology, Dr. Chen provides expertise in food allergy, chronic urticaria, and angioedema. She excels at addressing the impact of allergies on quality of life and productivity among the general population.
Driven by a desire to help people and deliver exceptional care, Dr. Chen takes great pride in the effectiveness and efficiency of her services, her attention to detail, and the excellent patient satisfaction scores she earns. She has trained and worked in a broad range of clinical care settings, including private practice, the Veterans Administration, major health systems, and academic medical centers, like Stanford Health Care.
Dr. Chen has extensive research experience, from study start-up to manuscript preparation. She has conducted trials on immunotherapy following administration of omalizumab (Xolair®), the treatment of mast cell disorders, and the ability of milk and egg allergic patients to tolerate different preparations of these foods.
She was principal investigator of a clinical trial studying the efficacy and safety of oral desensitization immunotherapy. She was also the PI of the MAGIC study, researching the efficacy and safety of dupilumab and milk oral immunotherapy for patients with an allergy to cow’s milk. In addition, Dr. Chen has served as an investigator on more than a dozen other trials studying new treatment regimens for peanut allergy, cow’s milk allergy, and other conditions.
She has presented the findings of her research to the American Academy of Allergy, Asthma, and Immunology Annual Scientific Meeting and other conferences. Dr. Chen has authored numerous scholarly publications on topics including biologic therapy for food allergy, asthma and food allergy, prevention of peanut allergy, and treatment of mast cell disorders.
Her work has appeared in the journals Pediatric Allergy; the Annals of Allergy, Asthma, and Immunology; JAMA; and, elsewhere. Dr. Chen co-wrote the chapter on allergic and immunological diseases in the book Basic Genetics and Epigenetics for the Immunologist and Allergist. She also co-wrote the chapter on complement deficiencies in the book Immunodeficiency Handbook.
Dr. Chen has received honors and awards for her scholarship. She is a member of the American Academy of Allergy, Asthma, and Immunology; the American College of Allergy, Asthma, and Immunology; and, the Allergy, Asthma, and Immunology Foundation of Northern California. She has volunteered her clinical services at homeless shelters in the Bay Area. -
Paul Cheng MD PhD
Instructor, Medicine
BioDr. Cheng is a Cardiologist and Instructor at Stanford University School of Medicine in the Department of Medicine. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. After finishing an internal medicine residency at Stanford, Paul has continued at Stanford as a fellow in cardiology. He is currently investigating molecular mechanisms behind genetic risk factors for human cardiovascular disease with a keen interest in amyloidosis, cardio-oncology, and atherosclerotic diseases. His current research focuses on the transcriptional regulation in smooth muscle cells utilizing both in vitro and in vivo models in combination with single-cell technologies to gain further insights into mechanisms that underlies genetic contributions to risk of human vascular and atherosclerotic diseases.
-
Xingxing Shelley Cheng
Clinical Assistant Professor, Medicine - Nephrology
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) pre-kidney transplant cardiovascular screening;
2) change in physical function with and without kidney transplant;
3) ethics of kidney allocation in multi-organ transplantation. -
Glenn M. Chertow
Norman S. Coplon/Satellite Healthcare Professor in Medicine and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease
-
Ramsey Cheung
Professor of Medicine (Gastroenterology and Hepatology) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly InterestsDr. Cheung's research interests focus on liver diseases, with emphasis on viral hepatitis. His past research include investigating the mechanism of viral neutralization of hepatitis B virus at the molecular level and immune response to hepatitis C virus. Dr. Cheung is studing various aspects of hepatitis C, both clinical and translational research.
-
Mildred Cho, PhD
Professor (Research) of Pediatrics (Center for Biomedical Ethics) and of Medicine (General Medical Disciplines)
Current Research and Scholarly InterestsDr. Cho's major areas of interest include: ethical and social issues in genetic research, including those arising from gene therapy and editing, synthetic biology, microbiome research, the use of artificial intelligence to analyze genomic and medical data, the effects of gene patenting on clinical genetic testing and research, and the impacts of academic-industry ties on biomedical research.
-
Jeff Choi
Masters Student in Biomedical Informatics, admitted Autumn 2020
Resident in Surgery - General SurgeryBioGeneral Surgery Resident (2017-) in professional development time. MSc student in Epidemiology & Clinical Research (2019-2020), and Biomedical Informatics (2020-). Co-President of SWAT (Surgeons Writing About Trauma); helping students get excited about clinical research is my passion.
My interest is encouraging cross-disciplinary collaborations to tackle challenging research questions in trauma surgery. To better lives of injured patients and their families, our research teams explore evidence synthesis (meta analysis), computer vision applications, decision analysis/cost-effectiveness analysis, epidemiological/clinical outcomes research, and prognostication tool development. If you are interested in collaborating, please reach out. -
Curtis R. Chong, MD, PhD, MPhil, FACP
Clinical Assistant Professor, Medicine - Oncology
BioDr. Chong was recruited to Stanford from the Memorial Sloan Kettering (MSK) Cancer Center, where he led MSK's launch of the early drug development and immunotherapy clinical trials program in New Jersey. At MSK, Dr. Chong was a member of the gastrointestinal oncology service and was one of two MSK physicians in New Jersey who specialized in treating melanoma. Prior to joining MSK, Dr. Chong was a member of the thoracic oncology service at the Dana-Farber Cancer Institute and an attending physician at the Massachusetts General Hospital and Brigham and Women's Hospital, all ailiates of Harvard Medical School.
Dr. Chong completed his categorical residency in internal medicine at the Massachusetts General Hospital/Harvard Medical School, his oncology fellowship at the Dana-Farber Cancer Institute, and is board-certified in internal medicine and medical oncology. He has received research support from the American Society of Clinical Oncology (Young Investigator Award), Uniting Against Lung Cancer, and the American Cancer Society. Dr. Chong has been published in the New England Journal of Medicine, Nature, Nature Medicine, Nature Chemical Biology, JAMA Oncology, and his research on drug discovery has been featured in the New York Times and Popular Science.
Born and raised in Honolulu where he attended public schools, Dr. Chong sang in the Honolulu Boy Choir, and was the 1993 Honolulu Star Bulletin Newspaper Boy of the Year. He received his A.B. in biochemical sciences from Harvard University magna cum laude followed by an M.Phil. in Chemistry with Sir Alan Fersht at the University of Cambridge (Emmanuel College). He then received his MD and PhD in pharmacology from The Johns Hopkins University School of Medicine.
An intrepid traveler and avid long-distance runner, Dr. Chong has visited 54 countries and completed 126 marathons in all 50 states, 18 countries, and 6 on continents. -
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor [Abbvie, Inc.], Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioWeihan Chu, M.D., is a clinical assistant professor at Stanford School of Medicine. He completed his M.D. degree at Case Western Reserve University and his Internship and Residency at Stanford Hospital. He has been working at Stanford Health Care ValleyCare Hospital as an academic hospitalist since 2015.
He serves as the Medical Informatics Director at SHC ValleyCare hospital and spends his time focused on leveraging technology to improve patient care. At SHC ValleyCare, he was the physician champion for the hospital's transition to electronic medical records and currently serves as the chair of the Physician IT Advisory Committee and the Clinical Decision Support Committee.
He interested in hospital based quality improvement projects. His past projects include the sepsis initiative at Stanford hospital and minimizing delay in obtaining outside hospital records.
In his spare time, he enjoys hiking, scuba diving, photography, and keeping up to date with the latest tech gadgets. -
Katrin Chua
Associate Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
Lorinda Chung
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology at the Palo Alto Veterans Affairs Health Care Center
Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.
-
John Clarke
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. John Clarke recently joined the Gastroenterology & Hepatology Division at Stanford University as Director of the Esophageal Program. He previously spent 17 years in Baltimore, including 9 years on the faculty at Johns Hopkins University where he was an Associate Professor and at various times Director of Esophageal Motility, Director of Gastrointestinal Motility, Clinical Director of the Johns Hopkins Center for Neurogastroenterology, and Clinical Director of the Gastroenterology & Hepatology Division at Johns Hopkins Bayview Medical Center.
His career has combined research, education and clinical care. His clinical areas of expertise include achalasia, dysphagia, eosinophilic esophagitis, esophageal dysmotility, gastroesophageal reflux disease, gastroparesis, GI-manifestations of scleroderma and GI dysmotility. While at Johns Hopkins University, he was inducted into The Miller-Coulson Academy for Clinical Excellence, an institutional honor society for master clinicians at the time limited to 50 members across the entire university.
From an education standpoint, he has lectured in over a dozen countries, authored over 25 textbook chapters and serves on the educational affairs committee of the American College of Gastroenterology. He has also won several major teaching awards, including The Johns Hopkins University Alumni Association Award for Excellence in Teaching, given to one faculty member per year in the entire School of Medicine.
His research has focused on optimization and characterization of diagnostic studies to evaluate motility disorders, as well the relationship between therapeutic endoscopic techniques and treatment of motility disorders. He was an investigator on the NIH Gastroparesis Consortium and is also a former recipient of the AGA Don Castell Award. -
Michael F. Clarke, M.D.
Karel H. and Avice N. Beekhuis Professor in Cancer Biology
Current Research and Scholarly InterestsDr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.
-
Shoa L. Clarke, MD, PhD
Instructor, Medicine
Instructor, Pediatrics - CardiologyBioDr. Clarke is a preventive cardiologist and an instructor at Stanford University School of Medicine in the Departments of Medicine and Pediatrics. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties. His research is focused on 1) understanding complex disease genetics in diverse populations, 2) integrating monogenic and polygenic risk with clinical risk, 3) large-scale phenotyping using the electronic health record. His clinical practice focuses on identifying risk factors for cardiovascular disease with the goal of promoting health and longevity through evidence-based personalized treatment. He is interested in developing family-centric approaches for the treatment of adults and children carrying high genetic risk for disease.
